Research Article
Alterations of Bone Metabolism in Patients with Diabetes Mellitus
Table 2
Characteristics of calcium-regulating hormones, bone markers, and BMD values.
| | Variables | DM1 (n = 98) | DM2 (n = 137) | Control (n = 82) |
| | PTH, ng/L | 51.16 (47.17–55.13) | 51.69 (48.82–54.56) | 45.09 (40.38–49.79) | | CT, ng/L | 12.07 (9.75–14.38) | 10.23 (8.48–11.62) | 5.5 (4.19–6.84) | | 25 (OH) D, nmol/L | 60.12 (53.21–67.04) | 62.69 (57.35–68.08) | 75.9 (67.26–84.51) | | ALP, IU/L | 118.3 (110.1–126.4) | 122.2 (116.2–128.1) | 123.5 (113.8–133.2) | | P1NP, ng/mL | 40.58 (37.18–43.98) | 42.08 (39.81–44.35) | 47.09 (42.82–51.35) | | b-CTX, ng/mL | 0.525 (0.468–0.582) | 0.495 (0.456–0.533) | 0.424 (0.383–0.466) | | Т-score (L1–L4) | −2.04 (−2.3; −1.7) | −1.08 (−1.3; −0.8) | −0.73 (−1.1; −0.3) | | Т-score (prox.) | −1.44 (−1.7; −1.1) | −0.95 (−1.2; −0.7) | −0.49 (−0.8; −0.1) | | Т-score (FN) | −1.68 (−1.9; −1.3) | −1.12 (−1.3; −0.8) | −0.64 (−1.0; −0.2) |
|
|
compared with the control group data. |
